+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Infectious Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Infectious Disease Therapeutics - Global Strategic Business Report

  • Report
  • September 2024
  • 94 Pages
  • Global
From
From
From
From
From
From
From
Antivirals Global Market Report 2024 - Product Thumbnail Image

Antivirals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Marburg virus disease - Pipeline Insight, 2024 - Product Thumbnail Image

Marburg virus disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Yellow fever - Pipeline Insight, 2024 - Product Thumbnail Image

Yellow fever - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Loading Indicator